- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 15, 2025 | 1.8M sh |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $1.56M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $1.95M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.71M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $2.11M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $6.54M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $7.43M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $9.48M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $10.43M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 17.67M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $21.95K |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | −$37.15K |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $9.34M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $9.66M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.01 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $315.79K |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $11.48K |
| Net Income | Q1 2025 · Mar 31, 2024 | −$103.76K |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$79.03K |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $365.03K |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $2.02M |
| Revenue | Q1 2025 · Mar 31, 2024 | $2.38M |